| Company Name: | Quidel Corporation | | Ticker Symbol: | QDEL | | | WWW Address: | www.quidel.com | | CEO: | Douglas C. Bryant | | No. of Employees: | 322 | | Common Issue Type: | CS | | Business Description: | The Company is engaged in the development, manufacturing and marketing of rapid diagnostic solutions for decentralized applications including point-of-care in infectious diseases and reproductive and women's health.
|
| | | Industry Information: | DRUGS - Diagnostic Support [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 13.23 |  0.02 | 12.31 | 14.12 | 13.18 | 13.28 | 13.09 | 394461 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 398.8 | 30.1 | 1.12 | 0.58 | 0.00 | 21.3 | 0.0 | 18.81 - 7.05 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 13.23 | $ | | PE Ratio - LTM | 21.3 | |
| Market Capitalisation | 398.8 | mil |
| Latest Shares Outstanding | 30.1 | mil |
| Earnings pS (EPS) | 0.58 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 397,925 | $ |
| Effective Tax Rate | 36.7 | % |
| Float | 25.5 | mil |
| Float as % of Shares Outstanding | 84.5 | % |
| Foreign Sales | 19 | mil |
| Domestic Sales | 109 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 27.50 | % |
| Research & Devlopment (R&D) as % of Revenue | 8.70 | % |
| Gross Profit Margin | 65.6 | % |
| EBITDA Margin | 29.4 | % |
| Pre-Tax Profit Margin | 22.6 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 12.6 | % |
| Return on Equity (ROE) | 16.0 | % |
| Return on Capital Invested (ROCI) | 15.3 | % |
| Current Ratio | 4.7 | |
| Leverage Ratio (Assets/Equity) | 1.3 | |
| Interest Cover | 48.7 | |
| Total Debt/Equity (Gearing Ratio) | 0.05 | |
| LT Debt/Total Capital | 4.0 | % |
| Working Capital pS | 2.89 | $ |
| Cash pS | 2.00 | $ |
| Book-Value pS | 3.92 | $ |
| Tangible Book-Value pS | 3.63 | $ |
| Cash Flow pS | 0.86 | $ |
| Free Cash Flow pS | 1.11 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.38 | |
| Price/Tangible Book Ratio | 3.65 | |
| Price/Cash Flow | 15.5 | |
| Price/Free Cash Flow | 12.0 | |
| P/E as % of Industry Group | 95.0 | % |
| P/E as % of Sector Segment | 11.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.0 | 99 | 4,188 | 10,870 |
| 4 Weeks | 15.17 | 12.84 | 14.30 | -7.5 | 87 | 3,658 | 62,189 |
| 13 Weeks | 18.81 | 12.84 | 15.53 | -14.8 | 79 | 4,342 | 264,839 |
| 26 Weeks | 18.81 | 12.84 | 12.71 | 4.1 | 86 | 3,597 | 449,610 |
| 52 Weeks | 18.81 | 7.05 | 13.63 | -2.9 | 79 | 4,133 | 1,029,095 |
| YTD | 18.81 | 7.05 | - | 1.2 | 83 | 4,253 | 965,439 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 13.31 | 13.58 | 15.02 | 14.55 | 13.23 | 1.12 | 0.96 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 10.86 | 95.0 | 7.51 |
| Income | 0.00 | 0.0 | 5.52 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 6.48 | NA | -22.92 |
| R&D | 0.66 | NA | -4.80 |
| Normalized Inc. | 43.98 | NA | 7.24 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 3.2 | 76.2 | 8.5 |
| Earnings % | 0.0 | 215.1 | 38.3 |
| EPS % | 7.7 | 233.3 | 41.5 |
| EPS $ | 0.03 | 0.35 | 0.17 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 59.94 |
| Current Ratio | 6.5 |
| Quick Ratio (Acid Test) | 5.4 |
| Liquidity Ratio (Cash) | 3.75 |
| Receivables Turnover | 5.3 |
| Average Collection Period | 68 |
| Working Capital/Equity | 71.8 |
| Working Capital pS | 2.70 |
| Cash-Flow pS | 0.87 |
| Free Cash-Flow pS | 0.77 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 12.66 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 16.5 |
| Total Debt/Equity (Gearing Ratio) | 0.06 |
| LT Debt/Equity | 0.05 |
| LT Debt/Capital Invested | 6.5 |
| LT Debt/Total Liabilities | 26.0 |
| Interest Cover | 45.4 |
| Interest/Capital Invested | 0.53 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.48 |
| Tobin's Q Ratio | 2.79 |
| Current P/E Ratio - LTM | 21.30 |
| Enterprise Value (EV)/EBITDA | 9.77 |
| Enterprise Value (EV)/Free Cash Flow | 19.17 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.65 |
| Price/Book Ratio - LTM | 3.38 |
| Price/Cash Flow Ratio | 15.5 |
| Price/Free Cash Flow Ratio - LTM | 12.0 |
| Price/Sales Ratio | 3.04 |
| P/E Ratio (1 month ago) - LTM | 24.3 |
| P/E Ratio (26 weeks ago) - LTM | 55.3 |
| P/E Ratio (52 weeks ago) - LTM | 21.6 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 95.0 |
| P/E as % of Sector Segment | 11.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 19.3 |
| PER SHARE FIGURES |
| LT Debt pS | 0.19 |
| Current Liabilities pS | 0.49 |
| Tangible Book Value pS - LTM | 3.63 |
| Book Value pS - LTM | 3.92 |
| Capital Invested pS | 4.16 |
| Cash pS - LTM | 2.00 |
| Cash Flow pS - LTM | 0.86 |
| Free Cash Flow pS - LTM | 1.11 |
| Earnings pS (EPS) | 0.58 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 19.09 |
| Free Cash Flow Margin 5YEAR AVG | 9.45 |
| Net Profit Margin | 14.7 |
| Net Profit Margin - 5YEAR AVRG. | 7.4 |
| Equity Productivity | 1.07 |
| Return on Equity (ROE) | 15.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.6 |
| Capital Invested Productivity | 1.02 |
| Return on Capital Invested (ROCI) | 15.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 7.1 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 13.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 6.1 |
| Gross Profit Margin | 65.6 |
| Gross Profit Margin - 5YEAR AVRG. | 62.9 |
| EBITDA Margin - LTM | 29.4 |
| EBIT Margin - LTM | 23.0 |
| Pre-Tax Profit Margin | 23.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 11.8 |
| Effective Tax Rate | 36.7 |
| Effective Tax Rate - 5YEAR AVRG. | -5.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 160 |
| Revenue per Employee | 397,925 |
| Net Income per Employee | 58,534 |
| Average Collection Period | 71 |
| Receivables Turnover | 5.3 |
| Day's Inventory Turnover Ratio | 89 |
| Inventory Turnover | 4.0 |
| Inventory/Sales | 9.1 |
| Accounts Payble/Sales | 3.37 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 1.50 |
| Fixed Assets Turnover | 3.07 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 2.21 |
| Revenue per $ Plant | 6.72 |
| Revenue per $ Common Equity | 1.07 |
| Revenue per $ Capital Invested | 1.02 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 29.3 |
| Research & Devlopment (R&D) as % of Revenue | 8.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 8.7 |
|
|  
|
| |
 |  |